Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by University of Colorado, Denver
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01951339
First received: September 19, 2013
Last updated: January 10, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)